MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) announces the appointment of Gregory Henderson, M.D., Ph.D., as President of Bio-Reference Laboratories (BRL), effective immediately. Dr. Henderson succeeds Marc Grodman, M.D., who is resigning, having served as Chairman, President and CEO of BRL since founding the company in 1981. OPKO acquired BRL in August 2015. Dr. Grodman will continue as a special advisor to OPKO and BRL to ensure a smooth transition.
